These effects, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the strategy of targeting ACKR3 as a singular method to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. It can also be lawfully sold https://shigesatou815mkl9.wikiexpression.com/user